Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2001
12/27/2001WO2001098485A1 Nucleic acid sequences and methods for the modification of plant gene expression
12/27/2001WO2001098484A1 Method for genome mining for secreted protein genes
12/27/2001WO2001098482A2 Liver-specific gene expression cassettes, and methods of use
12/27/2001WO2001098481A2 Renal regulatory elements and methods of use thereof
12/27/2001WO2001098480A2 Promoters for regulation of plant gene expression
12/27/2001WO2001098479A2 Plant resistance gene
12/27/2001WO2001098478A2 Clk-2, cex-7 and coq-4 genes, and uses thereof
12/27/2001WO2001098476A1 Polynucleotides encoding human serine proteases
12/27/2001WO2001098472A1 Novel glucose-6-phosphate dehydrogenase
12/27/2001WO2001098471A2 Human phosphodiesterases
12/27/2001WO2001098470A2 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same
12/27/2001WO2001098469A2 Polypeptides having peroxidase activity and nucleic acids encoding same
12/27/2001WO2001098468A2 Proteases
12/27/2001WO2001098465A1 Cds1 GENE-KNOCKOUT CELLS AND MOUSE AND UTILIZATION THEREOF
12/27/2001WO2001098460A2 Fusion proteins of mycobacterium tuberculosis
12/27/2001WO2001098455A2 Method for preparing a physiologically active il-18 polypeptide
12/27/2001WO2001098453A2 Modified construct downstream of the initiation codon for recombinant protein overexpression
12/27/2001WO2001098367A2 Neuroactive peptides for treatment of hypoxia and related conditions
12/27/2001WO2001098366A2 Enterokinase cleavage sequences and their use
12/27/2001WO2001098363A2 Peptides for use in the immunotherapy of renal cell carcinoma
12/27/2001WO2001098361A2 Agonist anti-trk-c monoclonal antibodies
12/27/2001WO2001098360A2 Gp354 nucleic acids and polypeptides
12/27/2001WO2001098359A2 Cyr61 as a target for treatment and diagnosis of breast cancer
12/27/2001WO2001098356A1 Low oxygen affinity mutant hemoglobins
12/27/2001WO2001098355A2 Cgi-69 compositions and methods of use
12/27/2001WO2001098354A2 Human receptors
12/27/2001WO2001098353A2 Secreted proteins
12/27/2001WO2001098351A2 G-protein coupled receptors
12/27/2001WO2001098350A2 Compositions comprising net-4 modulations and their use for treating neoplastic disease
12/27/2001WO2001098349A2 Recombinant avidin monomer and its use in biotin binding
12/27/2001WO2001098347A1 Canine liver cell growth factor
12/27/2001WO2001098346A2 Methods and compositions for the treatment of peripheral artery disease
12/27/2001WO2001098343A2 Conserved diaphanous-related formin autoregulatory domain (dad)
12/27/2001WO2001098342A1 Novel compounds
12/27/2001WO2001098341A1 Novel polypeptide and its dna
12/27/2001WO2001098340A2 Regulation of human mast cell protease 6-like enzyme
12/27/2001WO2001098338A2 Fluorescent proteins
12/27/2001WO2001098337A1 A novel polypeptide, a human uteroglobin 9 and the polynucleotide encoding the polypeptide
12/27/2001WO2001098336A1 A novel polypeptide, a human s4 ribosomal protein 10 and the polynucleotide encoding the polypeptide
12/27/2001WO2001098335A2 Transgenic algae for delivering antigens to an animal
12/27/2001WO2001098334A2 Streptococcus antigens
12/27/2001WO2001098333A2 Modification of hepatitis b core antigen
12/27/2001WO2001098332A2 Secreted redox proteins
12/27/2001WO2001098330A2 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS
12/27/2001WO2001098324A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
12/27/2001WO2001098323A2 G-protein coupled receptors
12/27/2001WO2001098321A1 Inhibition of human squamous cell carcinoma in vivo by egfr antisense rna
12/27/2001WO2001097868A1 The inactivation of nucleic acids using broad-spectrum pulsed light
12/27/2001WO2001097850A2 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
12/27/2001WO2001097839A1 Recombinant vaccines against infectious bursal disease virus
12/27/2001WO2001097828A2 Rhob as a suppressor of cancer cell growth and cell transformation
12/27/2001WO2001097781A1 Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake
12/27/2001WO2001097616A1 Protein expression profiling
12/27/2001WO2001097608A2 Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods
12/27/2001WO2001097607A2 Transgenic animal model of neurodegenerative disorders
12/27/2001WO2001078894A9 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
12/27/2001WO2001075087A8 Subtilisin variants
12/27/2001WO2001070967A3 Regulation of human serotonin-like g protein-coupled receptor
12/27/2001WO2001070254A9 Use of human not1 and not1a orphan receptors
12/27/2001WO2001068807A8 Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme
12/27/2001WO2001066243A3 Matrix reactor and a method for producing products in said reactor
12/27/2001WO2001062890A3 A process for generating genetically modified pearl millet through agrobacterium and biolistic transformation
12/27/2001WO2001062889A3 A process for generating cytoplasmic male sterile line in rice and other crops by rna editing
12/27/2001WO2001059088A3 Vector
12/27/2001WO2001055353A3 Recombinant attenuation of prrsv
12/27/2001WO2001055310A3 Nucleic acids, proteins, and antibodies
12/27/2001WO2001053525A3 Cell isolation method
12/27/2001WO2001053505A3 Herpes virus strains for gene therapy
12/27/2001WO2001051608A3 Hybrid cells obtainable from antigen presenting cells
12/27/2001WO2001051516A3 Fusion proteins for stimulating cytotoxic t-cells
12/27/2001WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity
12/27/2001WO2001048186A3 Induction of defence genes in plants transformed with mybnt1
12/27/2001WO2001046256A3 Vesicle trafficking proteins
12/27/2001WO2001044467A3 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators
12/27/2001WO2001044456A3 Antisense modulation of gene function in micro-organisms
12/27/2001WO2001042503A3 Apparatus and methods for drug screening based on nucleic acid analysis
12/27/2001WO2001042497A3 Monitoring oligonucleotide binding processes using chemiluminescence quenching
12/27/2001WO2001040459A3 Surface modified supporting materials for binding biological materials, method for the production and use thereof
12/27/2001WO2001038532A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
12/27/2001WO2001038490A3 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA
12/27/2001WO2001036453A3 Ny-eso-1 nanopeptide derivatives, and uses thereof
12/27/2001WO2001034811A3 Bacillus thuringiensis hybrid toxins
12/27/2001WO2001032711A3 Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof
12/27/2001WO2001031057A3 Double-strand nucleic acid probes and the use thereof
12/27/2001WO2001031042A3 Male-sterile brassica plants and methods for producing same
12/27/2001WO2001031019A3 Neisserial antigenic peptides
12/27/2001WO2001030990A3 Isolated nucleic acid sequence conferring salt tolerance in rice plant
12/27/2001WO2001029215A3 N-cam homolog and splice variants thereof
12/27/2001WO2001027297A3 VERSATILE rpL34 PROMOTER ELEMENTS AND USE THEREOF
12/27/2001WO2001027258A3 High yield protein expression system and methods
12/27/2001WO2001025456A3 Method for production of proteinaceous substances
12/27/2001WO2001012800A8 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds
12/27/2001WO2001000803A3 Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof
12/27/2001WO2001000799A8 Novel protein and dna thereof
12/27/2001WO2001000014A3 Test animal for atherosclerosis model and methods for testing and screening
12/27/2001WO2000029448A3 Human proteins having hydrophobic domains and dnas encoding these proteins
12/27/2001US20010056583 Genetically engineering eukaryotic cells; isolate genetically engineered cells, culture cells, recover preferential cells
12/27/2001US20010056581 Vectors and methods for the mutagenesis of mammalian genes
12/27/2001US20010056077 Pharmaceutical composition for treatment of duchenne muscular dystrophy
12/27/2001US20010056076 Treatment of acute lung injury and fibrosis with antagonists of alphavbeta6
1 ... 2913 2914 2915 2916 2917 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 ... 4023